The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was JOD 2.25 million compared to JOD 2.04 million a year ago. Net loss was JOD 0.541837 million compared to JOD 2.17 million a year ago.

Basic loss per share from continuing operations was JOD 0.008 compared to JOD 0.031 a year ago.